<p>Bar chart of number of evaluated solutions obtained by TS+PR and SA when applied on graph datasets in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0197103#pone.0197103.t012" target="_blank">Table 12</a> (phase I) for scalability testing.</p
<p>Bar graph depicting the contribution of complex versus POC laboratories to availability of tests ...
<p>Bonferroni statistical test (p-values) on number of evaluated solutions of the methods when appli...
<p>Graph—Characteristics of Pivotal Trials and FDA Review of Innovative Devices: This graph depicts ...
<p>Bar chart of the objective function values obtained by TS+PR and SA when applied on graph dataset...
<p>Bar chart of number of evaluated solutions obtained by the methods when applied on graph datasets...
<p>Bar chart of number of evaluated solutions obtained by the methods when applied on graph datasets...
<p>Box plot chart of the overall number of evaluated solutions obtained by TS+PR and SA when applied...
<p>Bar chart of the average number of evaluated solutions obtained by PR+TS, TS, and SA when applied...
<p>Bar chart of the average overall number of evaluated solutions obtained by PR+TS, TS, and SA when...
<p>Bar chart of the objective function values obtained by the methods when applied on graph datasets...
<p>Statistical analysis of the average overall number of evaluated solutions for TS, HC, and SA when...
<p>Statistical analysis of the average overall number of evaluated solutions obtained by PR+TS, TS, ...
<p>Box plot chart of the overall objective function values obtained by TS+PR and SA when applied on ...
<p>Bar chart of the objective function values obtained by the methods when applied on graph datasets...
<p>Bar chart of the average overall objective function obtained by PR+TS, TS, and SA when applied on...
<p>Bar graph depicting the contribution of complex versus POC laboratories to availability of tests ...
<p>Bonferroni statistical test (p-values) on number of evaluated solutions of the methods when appli...
<p>Graph—Characteristics of Pivotal Trials and FDA Review of Innovative Devices: This graph depicts ...
<p>Bar chart of the objective function values obtained by TS+PR and SA when applied on graph dataset...
<p>Bar chart of number of evaluated solutions obtained by the methods when applied on graph datasets...
<p>Bar chart of number of evaluated solutions obtained by the methods when applied on graph datasets...
<p>Box plot chart of the overall number of evaluated solutions obtained by TS+PR and SA when applied...
<p>Bar chart of the average number of evaluated solutions obtained by PR+TS, TS, and SA when applied...
<p>Bar chart of the average overall number of evaluated solutions obtained by PR+TS, TS, and SA when...
<p>Bar chart of the objective function values obtained by the methods when applied on graph datasets...
<p>Statistical analysis of the average overall number of evaluated solutions for TS, HC, and SA when...
<p>Statistical analysis of the average overall number of evaluated solutions obtained by PR+TS, TS, ...
<p>Box plot chart of the overall objective function values obtained by TS+PR and SA when applied on ...
<p>Bar chart of the objective function values obtained by the methods when applied on graph datasets...
<p>Bar chart of the average overall objective function obtained by PR+TS, TS, and SA when applied on...
<p>Bar graph depicting the contribution of complex versus POC laboratories to availability of tests ...
<p>Bonferroni statistical test (p-values) on number of evaluated solutions of the methods when appli...
<p>Graph—Characteristics of Pivotal Trials and FDA Review of Innovative Devices: This graph depicts ...
DOI
Add to ORKG